Profile: Nymox Corporation is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population. Our brands include AlzheimAlert™, TobacAlert™ and NicAlert™. Our AlzheimAlert™ is a painless, accurate and cost-effective urine test that aids physicians in the diagnosis of Alzheimer's disease. The test uses a first-morning urine sample to measure the level of a brain protein called neural thread protein (NTP) known to be elevated in patients suffering from Alzheimer's disease. Our NicAlert™ is a simple test to determine the smoking status. It is an easy-to-read test strip that can be used with either a saliva or a urine sample. It helps the parents to check whether their teenaged children are smoking.
FDA Registration Number: 3003106921
4 Products/Services (Click for related suppliers)
|
• Drug Mixture Control Materials (FDA Code: DIF / 862.3280) A clinical toxicology control material is a device intended to provide an estimation of the precision of a device test system and to detect and monitor systematic deviations from accuracy resulting from reagent or instrument defects. This generic type of device includes various single, and multi-analyte control materials. |
• Metabolites Cotinine Nicotine Test System (FDA Code: MRS / 862.3220) A carbon monoxide test system is a device intended to measure carbon monoxide or carboxyhemoglobin (carbon monoxide bound to the hemoglobin in the blood) in blood. Measurements obtained by this device are used in the diagnosis and treatment of or confirmation of carbon monoxide poisoning. |
• Saliva Testing |
• Urine Teststrips |